SUN PHARMACEUTICAL INDUSTRIES INC recalls Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada…
- Recall date
- January 27, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0342-2026
- FDA classification
- Class II
- Brand / firm
- SUN PHARMACEUTICAL INDUSTRIES INC
- Sold / distributed
- US Nationwide.
Why it was recalled
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7
Get recall alerts
Free email alert whenever SUN PHARMACEUTICAL INDUSTRIES INC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SUN PHARMACEUTICAL INDUSTRIES INC